ROTARIX has not been evaluated for carcinogenicity or mutagenicity. (VAN’s Note: This means that it hasn’t been safety tested to see if it causes cancer or if it mutates into another illness). Impairment of Fertility ROTARIX has not...
Read moreExcretion Excretion of the vaccine virus in the stools occurs after vaccination and lasts for 10 days on average with peak excretion around the 7th day. Viral antigen particles detected by ELISA were found in 50% of stools after the first dose...
Read moreThe immunologic mechanism by which ROTARIX protects against rotavirus gastro-enteritis is not entirely understood. A relationship between antibody responses to rotavirus vaccination and protection against rotavirus gastro-enteritis has not been...
Read moreIngredients: ROTARIX is a liquid suspension of the live attenuated RIX4414 strain of human rotavirus of the G1P[8] type for use in the prevention of rotavirus gastro-enteritis. The virus strain derived from the 89-12 strain is obtained by...
Read moreThe data sheet for Rotarix says: ‘The exact immunologic mechanism by which ROTARIX protects against rotavirus gastroenteritis is unknown….. Pharmacodynamics Immunogenicity: A relationship between antibody responses to rotavirus vaccination and...
Read more